The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Cardiovascular Disease Risk Among Cancer Survivors
Open accessAbstract
Background: Over 80% of adult patients diagnosed with cancer survive long-term. Long-term complications of cancer and its therapies may increase the risk of cardiovascular disease (CVD), but prospective studies utilizing adjudicated cancer and CVD events are lacking. Objectives: Assess the risk of CVD in cancer survivors in a prospective community-based study. Methods: We included 12,414 ARIC participants. Cancer diagnoses were ascertained via linkage with state registries supplemented with medical records. Incident CVD outcomes were coronary heart disease (CHD), heart failure (HF), stroke, and a composite of these endpoints. We used multivariable Poisson and Cox regression to estimate the association of cancer with incident CVD. Results: Mean age was 54, 55% were female, and 25% Black. 3,250 (25%) participants had incident cancer over a median 13.6 years of follow-up. Age-adjusted IR of CVD (per 1,000 person-years) were 27.0 (24.7, 29.1) for cancer survivors and 12.0 (11.5, 12.4) for non-cancer controls. After adjustment for cardiovascular risk factors, cancer survivors had significantly higher risks of CVD (HR 1.37, 95% CI 1.26, 1.50), HF (HR 1.52, 95% CI 1.38, 1.68), and stroke (HR 1.22, 95% CI 1.03, 1.44), but not CHD (HR 1.11, 95% CI 0.97, 1.28). Breast, lung, colorectal, and hematologic/lymphatic cancers, but not prostate cancer, were significantly associated with CVD risk. Conclusions: Compared to persons without cancer, adult cancer survivors have significantly higher risk of CVD, especially HF, independent of traditional cardiovascular risk factors. There is an unmet need to define strategies for CVD prevention in this high-risk population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Cancer treatment and survivorship statistics, 2019
Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21565 · Cited by 4,226
(1989) · PubMed · Cited by 3,139
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 2,924
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
Seidman, A. D., Hudis, C. A., Pierri, M. K., Shak, S., Paton, V. E., Ashby, M. A., Murphy, M., Stewart, S. J., & Keefe, D. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1215 · Cited by 1,563
Shared Risk Factors in Cardiovascular Disease and Cancer
Koene, R. J., Prizment, A. E., Blaes, A., & Konety, S. H. (2016) · Circulation · doi:10.1161/circulationaha.115.020406 · Cited by 1,494
Self-citationBluethmann, S. M., Mariotto, A. B., & Rowland, J. H. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0133 · Cited by 1,146
A population-based study of cardiovascular disease mortality risk in US cancer patients
Sturgeon, K. M., Deng, L., Bluethmann, S. M., Zhou, S., Trifiletti, D. M., Jiang, C., Kelly, S. P., & Zaorsky, N. G. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz766 · Cited by 923
Rosamond, W. D., Folsom, A. R., Chambless, L. E., Wang, C.-H., McGovern, P. G., Howard, G., Copper, L. S., & Shahar, E. (1999) · Stroke · doi:10.1161/01.str.30.4.736 · Cited by 811
Reappraising the role of inflammation in heart failure
Adamo, L., Rocha-Resende, C., Prabhu, S. D., & Mann, D. L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0315-x · Cited by 765
White, A. D., Folsom, A. R., Chambless, L. E., Sharret, A. R., Yang, K., Conwill, D., Higgins, M., Williams, O. D., Tyroler, H. A., & The ARIC Investigators (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00041-0 · Cited by 688
Causes of death among cancer patients
Zaorsky, N. G., Churilla, T. M., Egleston, B. L., Fisher, S. G., Ridge, J. A., Horwitz, E. M., & Meyer, J. E. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw604 · Cited by 657
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Moslehi, J. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1100265 · Cited by 635
Armenian, S. H., Xu, L., Ky, B., Sun, C., Farol, L. T., Pal, S. K., Douglas, P. S., Bhatia, S., & Chao, C. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0409 · Cited by 559
Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
Henriksen, P. A. (2018) · Heart · doi:10.1136/heartjnl-2017-312103 · Cited by 536
Cardiovascular Disease After Hodgkin Lymphoma Treatment: 40-Year Disease Risk
van Nimwegen, F. A., Schaapveld, M., Janus, C. P. M., Krol, A. D. G., Petersen, E. J., Raemaekers, J. M. M., Kok, W. E. M., Aleman, B. M. P., & van Leeuwen, F. E. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.1180 · Cited by 514
Strongman, H., Gadd, S., Matthews, A., Mansfield, K. E., Stanway, S., Lyon, A. R., dos-Santos-Silva, I., Smeeth, L., & Bhaskaran, K. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31674-5 · Cited by 509
Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment
Lenneman, C. G., & Sawyer, D. B. (2016) · Circulation Research · doi:10.1161/circresaha.115.303633 · Cited by 469
Nguyen, P. L., Je, Y., Schutz, F. A. B., Hoffman, K. E., Hu, J. C., Parekh, A., Beckman, J. A., & Choueiri, T. K. (2011) · JAMA · doi:10.1001/jama.2011.1745 · Cited by 432
Rosamond, W. D., Chang, P. P., Baggett, C., Johnson, A., Bertoni, A. G., Shahar, E., Deswal, A., Heiss, G., & Chambless, L. E. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.963199 · Cited by 349
Weaver, K. E., Foraker, R. E., Alfano, C. M., Rowland, J. H., Arora, N. K., Bellizzi, K. M., Hamilton, A. S., Oakley-Girvan, I., Keel, G., & Aziz, N. M. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0267-9 · Cited by 250
Weight change during chemotherapy in breast cancer patients: a meta-analysis
van den Berg, M. M. G. A., Winkels, R. M., de Kruif, J. T. C. M., van Laarhoven, H. W. M., Visser, M., de Vries, J. H. M., de Vries, Y. C., & Kampman, E. (2017) · BMC Cancer · doi:10.1186/s12885-017-3242-4 · Cited by 161
Byers, T., Wender, R. C., Jemal, A., Baskies, A. M., Ward, E. E., & Brawley, O. W. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21348 · Cited by 122
New-Onset Cardiovascular Morbidity in Older Adults With Stage I to III Colorectal Cancer
Kenzik, K. M., Balentine, C. J., Richman, J., Kilgore, M. L., Bhatia, S., & Williams, G. R. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9739 · Cited by 101
Joshu, C. E., Barber, J. R., Coresh, J., Couper, D. J., Mosley, T. H., Vitolins, M. Z., Butler, K. R., Nelson, H. H., Prizment, A. E., Selvin, E., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0696 · Cited by 66
Self-citationSchoormans, D., Vissers, P. A. J., van Herk‐Sukel, M. P. P., Denollet, J., Pedersen, S. S., Dalton, S. O., Rottmann, N., & van de Poll-Franse, L. V. (2018) · Cancer Medicine · doi:10.1002/cam4.1754 · Cited by 59
A New Equation to Estimate Glomerular Filtration Rate in Chinese Elderly Population
Liu, X., Wang, Y., Wang, C., Shi, C., Cheng, C., Chen, J., Ma, H., Lv, L., Li, L., & Lou, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079675 · Cited by 41
Coagulation and inflammation in long‐term cancer survivors: results from the adult population
Panova‐Noeva, M., Schulz, A., Arnold, N., Hermanns, I., Prochaska, J. H., Laubert‐Reh, D., Spronk, H. M. H., Blettner, M., Beutel, M. E., Pfeiffer, N., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13975 · Cited by 31
New onset of type 2 diabetes as a complication after cancer diagnosis: A systematic review
Jo, A., Scarton, L. J., O’Neal, L. J., Larson, S. A., Schafer, N., George, T. J., & Pena, J. M. M. (2020) · Cancer Medicine · doi:10.1002/cam4.3666 · Cited by 27
Cited by
Cardiovascular disease and cancer: shared risk factors and mechanisms
Wilcox, N. S., Amit, U., Reibel, J. B., Berlin, E., Howell, K., & Ky, B. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01017-x · Cited by 310
Tripathi, A., Arsha, S., Thapa, A., Thapa, S., Chand, S., Frishman, W. H., & Aronow, W. S. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000759 · Cited by 4
Metadata
- Authors
- Florido, R., Daya, N. R., Ndumele, C. E., Koton, S., Russell, S. D., Prizment, A., Blumenthal, R. S., Matsushita, K., Mok, Y., Felix, A. S., Coresh, J., Joshu, C. E., Platz, E. A., & Selvin, E.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 80
- Issue
- 1
- Pages
- 22-32
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W4283772666
- Cited by
- 319
- References
- 32
- FWCI
- 36.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.